NM_021098.3:c.149C>T

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_021098.3(CACNA1H):​c.149C>T​(p.Pro50Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000188 in 1,438,280 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P50S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000073 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

2
1
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 1.35

Publications

2 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.15974644).
BP6
Variant 16-1153886-C-T is Benign according to our data. Variant chr16-1153886-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 574192.
BS2
High AC in GnomAd4 at 11 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
NM_021098.3
MANE Select
c.149C>Tp.Pro50Leu
missense
Exon 2 of 35NP_066921.2O95180-1
CACNA1H
NM_001005407.2
c.149C>Tp.Pro50Leu
missense
Exon 2 of 34NP_001005407.1O95180-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
ENST00000348261.11
TSL:1 MANE Select
c.149C>Tp.Pro50Leu
missense
Exon 2 of 35ENSP00000334198.7O95180-1
CACNA1H
ENST00000569107.6
TSL:1
c.149C>Tp.Pro50Leu
missense
Exon 2 of 34ENSP00000454990.2H3BNT0
CACNA1H
ENST00000711493.1
c.149C>Tp.Pro50Leu
missense
Exon 2 of 34ENSP00000518778.1A0AAA9YHG8

Frequencies

GnomAD3 genomes
AF:
0.0000730
AC:
11
AN:
150646
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000268
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000657
AC:
5
AN:
76064
AF XY:
0.0000456
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000729
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000124
AC:
16
AN:
1287634
Hom.:
0
Cov.:
32
AF XY:
0.0000142
AC XY:
9
AN XY:
633648
show subpopulations
African (AFR)
AF:
0.000191
AC:
5
AN:
26150
American (AMR)
AF:
0.00
AC:
0
AN:
25066
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22280
East Asian (EAS)
AF:
0.0000738
AC:
2
AN:
27106
South Asian (SAS)
AF:
0.0000429
AC:
3
AN:
69968
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33020
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3884
European-Non Finnish (NFE)
AF:
0.00000584
AC:
6
AN:
1027500
Other (OTH)
AF:
0.00
AC:
0
AN:
52660
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000730
AC:
11
AN:
150646
Hom.:
0
Cov.:
30
AF XY:
0.0000952
AC XY:
7
AN XY:
73548
show subpopulations
African (AFR)
AF:
0.000268
AC:
11
AN:
41078
American (AMR)
AF:
0.00
AC:
0
AN:
15178
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5084
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4768
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10314
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
306
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67484
Other (OTH)
AF:
0.00
AC:
0
AN:
2066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.530
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.0000604
ExAC
AF:
0.000170
AC:
3

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV (1)
-
-
1
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
20
DANN
Benign
0.90
DEOGEN2
Benign
0.22
T
Eigen
Benign
-0.85
Eigen_PC
Benign
-0.88
FATHMM_MKL
Benign
0.069
N
LIST_S2
Benign
0.57
T
M_CAP
Pathogenic
0.98
D
MetaRNN
Benign
0.16
T
MetaSVM
Uncertain
0.078
D
MutationAssessor
Benign
0.69
N
PhyloP100
1.3
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.18
Sift
Benign
0.30
T
Sift4G
Benign
0.29
T
Polyphen
0.020
B
Vest4
0.076
MutPred
0.22
Loss of glycosylation at P50 (P = 0.0285)
MVP
0.56
ClinPred
0.017
T
GERP RS
2.0
PromoterAI
0.029
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.082
gMVP
0.33
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs746716155; hg19: chr16-1203886; API